Masimo Corporation (MASI) News
Filter MASI News Items
MASI News Results
|Loading, please wait...|
MASI News Highlights
- For MASI, its 30 day story count is now at 52.
- Over the past 25 days, the trend for MASI's stories per day has been choppy and unclear. It has oscillated between 1 and 10.
- ORI, CE and BDX are the most mentioned tickers in articles about MASI.
Latest MASI News From Around the Web
Below are the latest news stories about Masimo Corp that investors may wish to consider to help them evaluate MASI as an investment opportunity.
Technology-based healthcare stocks like Henry Schein (HSIC), Veeva Systems (VEEV) and BD (BDX) are expected to continue their rally over the next few months.
Masimo's (MASI) launch of SuperSensor can help clinicians to continuously monitor patients through one comprehensive, convenient, noninvasive fingertip solution.
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo announces the CE marking & European launch of the single-patient-use rainbow® SuperSensor, with 12 noninvasive parameters on a single sensor.
One Patient, One Sensor, 12 Parameters: Breakthrough Technology Offers Advanced Physiological Insight in One Comprehensive, Convenient, Noninvasive Fingertip Solution Masimo (NASDAQ: MASI) announc
NEUCHATEL, Switzerland, September 13, 2021--Masimo announces the CE marking & European launch of the single-patient-use rainbow® SuperSensor™, with 12 noninvasive parameters on a single sensor.
IRVINE, Calif., September 08, 2021--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, September 9, 2021 at 4:15 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation.
Masimo's (MASI) ORi is expected to provide early warnings of impending hypoxemia during the ETI procedure, thus aiding in averting any adverse incident.
New Study Investigates the Ability of Masimo ORi to Provide Early Warning of Hypoxemia During Endotracheal Intubation in ICU Patients
Researchers Found That Use of ORi May Facilitate "Preventive Action" Against Hypoxemia Masimo (NASDAQ: MASI) announced today the findings of a prospective, blinded observational study published in
(RTTNews) - Masimo (MASI) said researchers concluded that the time between decrease in ORi and subsequent decrease in oxygen saturation or SpO2 "may allow preventive action," and that a higher ORi value during preoxygenation was "independently protective against hypoxemia". The company noted that Dr. Jean-Baptiste Lascarrou and colleagues at
Masimo (MASI) partners with Penington Institute to increase awareness on overdose from prescription opioids.